株式会社極東書店トップ ＞ 商品一覧 ＞ Multiregional Clinical Trials for Simultaneous Global New Drug Development.
商品詳細
Multiregional Clinical Trials for Simultaneous Global New Drug Development.
・ISBN 978-0-367-73722-1 paper GB£ 54.99
￥17,420.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
| 著者・編者 | Chen, Joshua / Quan, Hui (eds.), |
|---|---|
| シリーズ | (Chapman & Hall/CRC Biostatistics Series) |
| 出版社 | (Chapman & Hall/CRC, UK) |
| 出版年月 | 2020 |
| ページ数 | 353 pp. |
| 言語 | ENG |
| ニュース番号 | ＜A00-44992＞ |
解説
In a global clinical development strategy, multiregional clinical trials (MRCTs) are vital in the development of innovative medicines. Multiregional Clinical Trials for Simultaneous Global New Drug Development presents a comprehensive overview on the current status of conducting MRCTs in clinical development. International experts from academia, industry, and health organizations address various aspects of the important problems in global clinical development and MRCTs.
The book first provides a high-level introduction to the context, motivation, opportunities, and challenges in simultaneous global clinical development using MRCTs. It then focuses on the design, monitoring, and analysis/interpretation of MRCTs. The book concludes with an examination of the latest research topics from MRCT perspectives, such as special considerations by local health authorities, health economic evaluations, benefit-risk assessment, and medical devices.
Explaining how to design, conduct, and interpret MRCTs, this book will help biostatisticians working in the late-stage clinical development of medical products. It will also be useful for statisticians and clinicians in the biopharmaceutical industry, regulatory agencies, and medical research institutes.